Emergency BU Alert Boston University's Charles River and Medical Center Campuses will be closed all day Tuesday, January 27, 2015. BU Medical Campus CLOSED Tuesday, Jan. 27, 2015 Boston University Medical Campus will be closed Tuesday, Jan. 27. All normal academic and administrative activities have been canceled. Employees in essential services should report as scheduled. Essential services include, but are not limited to Public Safety, Facilities Management, Emergency Patient Treatment, Office of Environmental Health and Safety, Occupational and Environmental Medicine, and Mail Service. Medical, PA and GMS students who are assigned to inpatient services or clinics are expected to be present, if possible. Students who are assigned to outpatient services should check with their course directors or the policy at the clinical site. For the very latest information, please go to BU Today at http://www.bu.edu/today and the Emergency Communications page at http://www.bu.edu/ehs/comm

Jane Freedman Ph.D.

Medicine-Cardiology

Office: W-507
Phone: 617-638-4022
Email:
freedmaj@bu.edu

Research:

The major research initiatives in Dr. Freedman’s laboratory emphasize the regulation of pathways contributing to atherothrombotic disease and how these factors contribute to acute coronary syndromes. A major initiative in the laboratory is examining the role of immunity, infection, and inflammation on atherothrombotic (specifically platelet function) disease through cell culture and animal studies. Drs. Genco, Ingalls, and Freedman have worked together on studies to define the role of platelets specific TLR signaling in response to microbial stimulation. In addition, Dr. Freedman is funded by the NHLBI to study gene expression in circulating cells (platelets and leukocytes) in the Offspring Cohort at the Framingham Heart Study. Gene expression, particularly genes related to atherothrombosis, are being studied to determine the relation with cardiovascular risk factors, phenotypes, and genetics. Dr. Freedman is also a member of the Framingham SABR project and her laboratory is specifically examining the relation of miRNA to cardiovascular disease in the Offspring Cohort of the Framingham Heart Study.

Affiliated Websites:

Pharmacology and Experimental Therapeutics Webpage